HELPING THE OTHERS REALIZE THE ADVANTAGES OF SGT-67 IN ITALIA

Hepatic Impairment Following oral administration of an individual four mg dose (2 mg hydromorphone quick-release tablets), suggest publicity to hydromorphone (Cmax and AUC∞) is amplified four-fold in clients with average (Child-Pugh Group B) hepatic impairment when compared with topics with standard hepatic functionality. Due to greater exposure